SIR-Spheres microspheres
Showing 1 - 25 of 288
Colorectal Tumors Trial in Hangzhou (Resin microspheres containing yttrium-90 (Y-90))
Not yet recruiting
- Colorectal Neoplasms
- Resin microspheres containing yttrium-90 (Y-90)
-
Hangzhou, Zhejiang, ChinaSir Run Run Shaw Hospital (SRRSH), affiliated with the Zhejiang
Oct 11, 2023
Liver Cancer Trial in France (Yttrium-90 loaded SIR-Spheres microspheres, QLQ-C30 with HCC module)
Completed
- Liver Cancer
- Yttrium-90 loaded SIR-Spheres microspheres
- QLQ-C30 with HCC module
-
Angers, France
- +12 more
Aug 12, 2022
Stage IV Uveal Melanoma Trial in Philadelphia (Sir-Spheres®)
Active, not recruiting
- Stage IV Uveal Melanoma
- Sir-Spheres®
-
Philadelphia, PennsylvaniaThomas Jefferson University
Dec 20, 2022
Unresectable Hepatocellular Carcinoma (HCC), Liver Metastases From Colorectal Cancer (mCRC) Trial in France, Spain, United
Recruiting
- Unresectable Hepatocellular Carcinoma (HCC)
- Liver Metastases From Colorectal Cancer (mCRC)
- SIRT
-
Clichy, Cedex, France
- +8 more
Jul 31, 2023
HCC, Cancer of Liver, Cancer Trial in Atlanta (SIR-Spheres microspheres)
Completed
- HCC
- +2 more
- SIR-Spheres microspheres
-
Atlanta, Georgia
- +2 more
Dec 22, 2021
Neuroendocrine Tumors, Gastrointestinal Tumors, Carcinoid Tumors Trial in Denver, Kansas City, Nashville (Lanreotide, Y-90
Terminated
- Neuroendocrine Tumors
- +2 more
- Lanreotide
- Y-90 microspheres
-
Denver, Colorado
- +2 more
Jul 5, 2022
Intrahepatic Cholangiocarcinoma Trial in Charleston (SIR-Spheres microspheres (Yttrium-90 Microspheres), Gemcitabine, Cisplatin)
Active, not recruiting
- Intrahepatic Cholangiocarcinoma
- SIR-Spheres microspheres (Yttrium-90 Microspheres)
- +2 more
-
Charleston, South CarolinaMedical University of South Carolina
Nov 11, 2021
Unresectable Hepatocellular Carcinoma, BCLC Stage A Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma Trial in
Recruiting
- Unresectable Hepatocellular Carcinoma
- +3 more
- Resin microspheres containing yttrium-90 (Y-90)
-
Mission Hills, California
- +15 more
Sep 15, 2022
Utilizing Flex-dosing for Unresectable HCC With Y90 SIR-Spheres
Recruiting
- Hepatocellular Carcinoma
- SIRT with Y-90 resin microspheres
-
Dallas, TexasMethodist Dallas Medical Center
Nov 9, 2021
Carcinoma, Hepatocellular, Hepatoma Trial in United States (SIR-Spheres microspheres)
Terminated
- Carcinoma, Hepatocellular
- Hepatoma
- SIR-Spheres microspheres
-
Philadelphia, Pennsylvania
- +3 more
Nov 16, 2020
Hepatectomy Trial in Cologne (SIRT followed by liver resection or liver transplantation)
Recruiting
- Hepatectomy
- SIRT followed by liver resection or liver transplantation
-
Cologne, GermanyUniversity of Cologne, Department of General, Visceral and Cance
Mar 1, 2022
Metastatic Liver Carcinoma, Stage IV Liver Cancer, Stage IVA Liver Cancer Trial in Houston (procedure, radiation, other)
Active, not recruiting
- Metastatic Liver Carcinoma
- +3 more
- Angiography
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Sep 22, 2022
Intrahepatic Cholangiocarcinoma Trial in Worldwide (Cisplatin-gemcitabine, Radiation: SIRT + chemo (cisplatin-gemcitabine))
Active, not recruiting
- Intrahepatic Cholangiocarcinoma
- Cisplatin-gemcitabine
- Radiation: SIRT + chemotherapy (cisplatin-gemcitabine)
-
Spokane, Washington
- +22 more
Apr 1, 2022
Uveal Melanoma Trial in Berlin (SIRT, DSM-TACE)
Recruiting
- Uveal Melanoma
- SIRT
- DSM-TACE
-
Berlin, GermanyCharité - University Medicine Berlin, Dept. of Haematology, Medi
Nov 8, 2021
Carcinoma, Carcinoma, Hepatocellular, Liver Tumor Trial in Spokane (99mTc-Macro Albumin Aggregate)
Recruiting
- Carcinoma
- +2 more
- 99mTc-Macro Albumin Aggregate
-
Spokane, WashingtonInland Imaging
May 4, 2023
Liver Carcinoma Trial in Vienna (Yttrium-90 loaded SIR-Spheres microspheres, QLQ-C30 with HCC module)
Completed
- Liver Carcinoma
- Yttrium-90 loaded SIR-Spheres microspheres
- QLQ-C30 with HCC module
-
Vienna, AustriaCardiovascular and Interventional Radiological Society of Europe
Jan 17, 2020
Yttrium Y 90 Resin Microspheres Data Collection in Unresectable
Completed
- Localized Non-Resectable Adult Liver Carcinoma
- Yttrium-90 Resin Microspheres
-
Birmingham, Alabama
- +41 more
Sep 3, 2021
Colon Cancer, Rectal Cancer, Liver Metastases Trial in San Francisco (Tas-102, SIR-Sphere)
Completed
- Colon Cancer
- +2 more
- Tas-102
- SIR-Sphere
-
San Francisco, CaliforniaUniversity of California San Francisco
Jul 28, 2022
Neuroendocrine Tumor Grade 2, Neuroendocrine Tumors Trial in Little Rock, Buffalo, Philadelphia (Capecitabine Oral Product,
Recruiting
- Neuroendocrine Tumor Grade 2
- Liver Metastases
- Capecitabine tablets + temozolomide tablets + SIR-Spheres
-
Philadelphia, PennsylvaniaAbramson Cancer Center
Oct 1, 2021
Hepatocellular Cancer Trial in Honolulu (Sorafenib, yttrium-90 radioembolization)
Withdrawn
- Hepatocellular Cancer
- Sorafenib
- yttrium-90 radioembolization
-
Honolulu, HawaiiUniversity of Hawaii
Nov 6, 2019
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Carcinoma in the Liver Trial in Atlanta
Not yet recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +3 more
- Y-90 SIR-Spheres
- +2 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Jun 7, 2022
Colorectal Cancer Metastatic Trial in Worldwide (FOLFOX6m, SIR-Spheres microspheres)
Completed
- Colorectal Cancer Metastatic
- FOLFOX6m
- SIR-Spheres microspheres
-
Duarte, California
- +82 more
Oct 23, 2019
Hepatocellular Carcinoma Trial in Magdeburg (RFA, Radioembolization (SIRT))
Completed
- Hepatocellular Carcinoma
- RFA
- Radioembolization (SIRT)
-
Magdeburg, GermanyUniversity of Magdeburg
May 29, 2019
Uveal Melanoma, Hepatic Metastases Trial in San Francisco, Chicago, Philadelphia (SIR-Spheres® Yttrium 90, ipilimumab,
Active, not recruiting
- Uveal Melanoma
- Hepatic Metastases
- SIR-Spheres® Yttrium 90
- +2 more
-
San Francisco, California
- +2 more
Apr 15, 2021